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Lucy Liaw, 2 and Tamara King   1 Objective. Exercise is commonly recommended for patients with osteoarthritis (OA) pain. However, whether exercise is beneficial in ameliorating ongoing pain that is persistent, resistant to nonsteroidal antiinflammatory drugs (NSAIDs), and associated with advanced OA is unknown.
Methods. Rats treated with intraarticular (IA) monosodium iodoacetate (MIA) or saline underwent treadmill exercise or remained sedentary starting 10 days postinjection. Tactile sensory thresholds and weight bearing were assessed, followed by radiography at weekly intervals. After 4 weeks of exercise, ongoing pain was assessed using conditioned place preference (CPP) to IA or rostral ventromedial medulla (RVM)-administered lidocaine. The possible role of endogenous opioids in exercise-induced pain relief was examined by systemic administration of naloxone. Knee joints were collected for micro-computed tomography (micro-CT) analysis to examine pathologic changes to subchondral bone and metaphysis of the tibia.
Results. Treadmill exercise for 4 weeks reversed MIA-induced tactile hypersensitivity and weight asymmetry. Both IA and RVM lidocaine D35, administered post-MIA, induced CPP in sedentary but not exercised MIA-treated rats, indicating that exercise blocks MIAinduced ongoing pain. Naloxone reestablished weight asymmetry in MIA-treated rats undergoing exercise and induced conditioned place aversion, indicating that exercise-induced pain relief is dependent on endogenous opioids. Exercise did not alter radiographic evidence of OA. However, micro-CT analysis indicated that exercise did not block lateral subchondral bone loss or trabecular bone loss in the metaphysis, but did block MIA-induced medial bone loss.
Conclusion. These findings support the conclusion that exercise induces pain relief in advanced, NSAIDresistant OA, likely through increased endogenous opioid signaling. In addition, treadmill exercise blocked MIAinduced bone loss in this model, indicating a potential bone-stabilizing effect of exercise on the OA joint.
Osteoarthritis (OA) is the most prevalent chronic joint disease worldwide, with incidence predicted to rise due to the aging population and the impact of obesity (1) (2) (3) (4) (5) . OA is characterized by cartilage degradation and bone remodeling, observable on radiographs as diminished joint space and bony growths within the joint (6) . Microcomputed tomography (micro-CT) analysis of OA joints indicates development of subchondral bone remodeling that corresponds to cartilage loss (7) . Notably, the degree of joint pain does not correlate with radiographic evidence of pathology, although other imaging modalities such as magnetic resonance imaging (MRI) demonstrate that development of synovitis correlates with the presence of knee pain even in the absence of radiographic signs of OA (3, 8, 9) .
OA can be a debilitating condition, with pain being the most common OA symptom for which patients present to primary care practitioners (10) . OA pain is typically characterized by predictable sharp pain that is associated with movement or use of the joint (10) . Some patients develop advanced OA, which is characterized by nonsteroidal antiinflammatory drug (NSAID)-resistant, constant, dull, and aching pain, interspersed with short unpredictable episodes of intense pain (10, 11) .
Current treatments focus on alleviating pain and stiffness (12) . Oral NSAIDs or duloxetine are the most common pharmacologic treatments (13, 14) . Surgery consists primarily of joint replacement options that are successful for most patients (15) . However, the prevalence of OA is increasing in younger populations for whom total Figure 1 . Alleviation of monosodium iodoacetate (MIA)-induced weight asymmetry and tactile hypersensitivity following treadmill exercise. A, Experimental procedure used to examine the effects of treadmill exercise on MIA-induced tactile hypersensitivity and weight asymmetry. B, Selective reversal of tactile hypersensitivity in exercised rats. Treadmill exercise starting 10 days post-MIA injection selectively reversed tactile hypersensitivity in exercised rats by day 35 after MIA treatment, corresponding to 4 weeks of exercise. * 5 P , 0.05; ** 5 P , 0.01; *** 5 P , 0.001 versus baseline (BL); ## 5 P , 0.01 versus week 1. C, Reversal of weight asymmetry in exercised rats. Treadmill exercise starting 10 days post-MIA injection into the knee joint reversed weight asymmetry in exercised but not sedentary rats, with improvement observed by day 21 after treatment, corresponding to 2 weeks of exercise, and continued improvement between days 35 and 49 after treatment. * 5 P , 0.05; ** 5 P , 0.01; *** 5 P , 0.001 versus BL; # 5 P , 0.05; ## 5 P , 0.01; ### 5 P , 0.001 versus week 1. D, Average number of shocks per weekly treadmill session in MIA-treated rats. During the first week of treadmill exercise, the average number of shocks per weekly session demonstrates quick adaptation to running on the treadmill. *** 5 P , 0.05 versus days 11, 12, and 13. E, Average number of shocks per daily treadmill session in MIA-treated rats. Across the 4-week treatment period, the average number of shocks per daily session demonstrates elevation only during the first day of the first week of treadmill training. Values are the mean 6 SEM. knee replacement may not be optimal, as this procedure was originally designed for patients age .70 years old (15) .
Exercise is the most commonly recommended method of nonpharmacologic intervention (14) . Clinical studies have demonstrated that aerobic and strengthening exercises improve joint function and pain in patients with OA (16) . Preclinical studies have demonstrated that exercise across a period of weeks alleviated hypersensitivity in a variety of rodent models of chronic pain (17) (18) (19) (20) (21) (22) (23) (24) . Blockade of opioid signaling has been shown to reverse exerciseinduced pain relief in models of nerve injury (17) . The present study examined the hypothesis that treadmill exercise blocks weight asymmetry and ongoing pain through enhanced opioidergic signaling in a rat model of advanced knee OA pain, previously shown to produce persistent NSAID-resistant ongoing pain (25) .
MATERIALS AND METHODS
Animals. Male Sprague-Dawley rats (Harlan) weighing 175-200 gm were housed with a 12-hour light/dark cycle, with food and water available ad libitum. Rats were group housed, except those that had undergone cannulation surgery of the rostral ventromedial medulla (RVM), which were individually housed starting immediately postsurgery. All experiments were performed in accordance with policies and recommendations of the International Association for the Study of Pain and the National Institutes of Health guidelines for the handling and use of laboratory animals. All experimental protocols received approval from the Institutional Animal Care and Use Committee of the University of New England.
Study design. Tactile hypersensitivity and weight asymmetry. Figure 1A demonstrates the protocol used to determine the impact of exercise on MIA-induced tactile hypersensitivity and weight asymmetry. Pre-MIA treatment (baseline) assessment of tactile sensory thresholds was performed, followed by assessment of hind limb weight bearing. MIA (4.8 mg/60 ml) was injected intraarticularly (IA) through the infrapatellar ligament of the left knee under isoflurane (2% in O 2 ), as previously described (25) (26) (27) . Tactile sensory thresholds and, subsequently, weight asymmetry were assessed 7 days postinjection to verify initiation of MIA-induced tactile hypersensitivity and weight asymmetry.
Starting 10 days after IA injection of MIA or saline, rats were randomly assigned to the exercise or sedentary treatment groups. Treadmill sessions were performed using a 3-lane treadmill (Columbus Instruments) for 30 minutes daily over a sequential 4-day period, as previously described (17) . For exercise rats, treadmill speed was 12 meters/minute during the first week of exercise (postinjection days 10-13), increased to 16 meters/ minute starting the second week (postinjection days [17] [18] [19] [20] , and continued at this rate through the remainder of the study. Sedentary control rats were placed on the treadmill at the stationary setting for 30 minutes. The treadmill was cleaned with 70% ethanol between groups of rats. Weight bearing and then tactile sensory thresholds were determined the fifth day of each week, 20-24 hours after the last treadmill session. No exercise or behavioral testing occurred during days 6 or 7 of each week.
The experiments included 6 exercise and 6 sedentary rats treated with MIA for tactile sensory testing, and 11 exercise and 10 sedentary rats treated with MIA for analysis of weight bearing (33 rats total). Three of 36 rats were removed as they failed to show MIA-induced weight asymmetry (defined as weight distribution [left/right 3 100] of 85% or higher) and tactile hypersensitivity (defined as failure to respond at cutoff von Frey filament of 15 gm). The experimenters (JA and IA) were aware of the treatment condition of each rat during behavioral testing.
Conditioned place preference (CPP) measure of ongoing pain. Figure 2A shows the protocol used to determine the impact of exercise on MIA-induced ongoing pain. Rats received IA injections of MIA (4.8 mg/60 ml) or an equal volume of saline, followed by verification of development of weight asymmetry 7 days later. Rats that failed to show weight asymmetry were removed from the study (7 of 75 rats that had received IA lidocaine; 0 of 65 rats that had received RVM lidocaine). Saline-and MIA-treated rats were randomly divided into the treadmill exercise or sedentary treatment groups, resulting in a 2 3 2 experimental design ([saline, MIA] 3 [exercise, sedentary]). CPP in response to pain relief, induced by IA or RVM administration of lidocaine, was assessed using a single-trial conditioning protocol on days 34-36 after IA injection, which corresponded to week 4 of treadmill exercise.
On day 34 (during the preconditioning period), rats were placed into the CPP apparatus with access to all 3 chambers, and baseline time spent in each chamber was measured for 15 minutes using webcams and video analysis (performed with the computer program Any-maze [Stoelting]). Rats spending ,180 or .720 seconds in a pairing chamber during baseline testing were removed from the study (1 of 55 rats in the IA lidocaine experiment and 9 of 65 rats in the intra-RVM lidocaine experiment). Drug-chamber pairings were counterbalanced across subjects. On day 35, single-trial conditioning was performed for either the IA lidocaine or the RVM lidocaine experiment.
IA lidocaine. While under isoflurane anesthesia, rats received IA saline (200 ml) injected into the ipsilateral knee joint and were immediately confined to the pre-assigned pairing chamber for 30 minutes (within 2 minutes of injection). They were then returned to their home cages. Four hours later, rats received IA lidocaine (200 ml 4% [weight/volume]) while under isoflurane anesthesia, and were immediately confined to the opposite pairing chamber for 30 minutes. All rats awoke prior to placement into the pairing chambers. Of the saline-treated rats, a total of 10 sedentary and 9 exercise rats were tested and of the MIA-treated rats, a total of 18 sedentary and 18 exercise rats were tested.
RVM lidocaine. Rats received RVM microinjection of sterile saline (0.5 ml/minute), with the injector remaining in place for 1 minute postinjection to prevent backflow. Rats were immediately confined to the pre-assigned pairing chamber for 30 minutes (within 2 minutes of injection) and then returned to their home cages. Four hours later, rats received a microinjection of RVM lidocaine (4% [w/v], 0.5 ml/minute) and were immediately confined to the opposite pairing chamber for 30 minutes. Following verification of cannula placement, a total of 9 saline-treated sedentary, 10 saline-treated exercise, 11 MIA-treated sedentary, and 9 MIA-treated exercise rats were included in the data analysis. Seventeen of 56 rats were eliminated from the data analysis due to missed cannula placement. On day 36, rats were placed in the 3-chamber apparatus with access to all chambers for 15 minutes and time in each chamber was recorded.
Effects of systemic administration of naloxone on place preference and weight bearing. Following preinjection assessment of weight bearing, rats were injected intraarticularly with MIA and were tested for weight asymmetry weekly throughout the treadmill exercise, as described above. On day 35, rats underwent pre-naloxone testing followed by injection of naloxone (3 mg/kg, intraperitoneally [IP]). Weight-bearing measurements were then repeated 30 minutes after naloxone treatment. A total of 6 MIA-treated sedentary and 6 MIA-treated exercise rats were tested. The experimenter was blinded with regard to the treatment condition during behavioral testing.
A single-trial conditioning protocol was performed 34-36 days post-IA injection, with baseline (day 34) and test (day 36) procedures performed as described above. On day 35 (conditioning day), rats underwent systemic administration of saline (IP) and were immediately confined to the pre-assigned pairing chamber for 30 minutes. They were returned to their home cages and underwent systemic administration of naloxone (3 mg/kg, IP) 4 hours later, followed immediately by confinement to the opposite pairing chamber for 30 minutes. A total of 12 saline-treated sedentary, 16 saline-treated exercise, 20 MIA-treated sedentary, and 15 MIA-treated exercise rats were tested.
Experimental procedures. Tactile hypersensitivity. Tactile sensory thresholds were assessed using calibrated von Frey filaments (ranging from 0.41 to 15 gm) and the up-down method, analyzed by Dixon nonparametric test, and expressed as the mean withdrawal threshold on the ipsilateral hind paw, as previously described (28, 29) .
Weight asymmetry. Baseline testing was performed prior to IA MIA injections and at weekly intervals through 49 days postinjection. Changes in hind paw weight distribution between the left (MIA) and right (contralateral) limbs were measured using an incapacitance tester (Stoelting) and were used as an index of joint discomfort in the MIA-treated knee (26) . Rats were placed in an angled plexiglass chamber, and positioned so that each hind paw rested on a separate force plate. The force exerted by each hind limb was determined over a 5-second period. Each data point is the mean of 3 readings. As previously described (26) , data were normalized as the percent injured/ uninjured weight bearing, with equal weight distribution indicated by 100% and sensitivity on the injured side indicated by values of ,100%.
Rostral ventromedial medulla cannula surgery. Rats underwent RVM cannula surgery under anesthesia (100 mg/kg ketamine and 10 mg/kg xylazine, administered IP) 28 days postinjection using stereotaxic techniques as previously described (26) . Bilateral 26-gauge guide cannulas, separated by 1.2 mm, were directed toward the lateral portions of the RVM (anteroposterior, 11.0 mm from the bregma; lateral 6 0.6 mm; dorsoventral 8.5 mm from the skull), according to Paxinos and Watson (30) . Guide cannulas were secured to the skull by small stainless steel machine screws and cemented in place. Animals were allowed to recover 3 days postsurgery before returning to the treadmill for the fourth week of exercise, days 31-33 postinjection. RVM microinjections (0.5 ml) were administered over a period of 1 minute through a 33-gauge injector that protruded 1 mm beyond the end of the guide cannula and into fresh tissue to prevent backflow. Cannula placement was verified at the end of the study by microinjection (0.5 ml/1 minute) of Evans blue dye (50 mg/ml; Sigma Aldrich).
Radiographic imaging. Through day 28 post-IA injection, radiographic images were obtained on a weekly basis following behavioral testing. Radiography was not performed during CPP in order to avoid disruption of the learning process. To limit movement during the imaging, rats were lightly anesthetized with a 2% isoflurane/O 2 mixture, and radiographic images of the knee joint were captured using a digital x-ray system (Fujifilm Medical Systems).
Micro-computed tomography (micro-CT). Following behavioral analyses for the naloxone-induced weight asymmetry experiment (day 42 post-MIA injection), rats were euthanized and knee joints dissected and fixed in 10% neutral buffered formalin for 3 days. The joints were then transferred to 70% ethanol. To characterize exercise-induced changes in joint microarchitecture, the proximal tibias were analyzed with a Scanco VivaCT-40 scanner. Joints were loaded into 12.3 mm-diameter scanning tubes. Scans were integrated into 3-dimensional voxel images (2,048 3 2,048-pixel matrices for trabecular and 1,024 3 1,024-pixel matrices for all other individual planar stacks). Rat tibias were scanned at low resolution, at an energy level of 55 kVp and intensity of 145 mA.
Trabecular bone volume fraction and microarchitecture of the proximal metaphyseal region were evaluated below the growth plate. Approximately 375 consecutive slices were made at 10.5-mm intervals at the distal end of the growth plate, extending in a proximal direction, and 250 contiguous slices were selected for analysis. Subchondral trabecular bones were scanned at low resolution, at an energy level of 55kVp and intensity of 145 mA at 10.5 mm.
Subchondral trabecular bone in the medial and lateral tibial plateau was analyzed over 50 cross-sections. The volume of interest included the subchondral trabecular bone starting below the subchondral plate, extending distally toward the growth plate. The images were segmented using a threshold of 260. The 3-dimensional morphometric parameters were calculated for the medial, lateral, and total subchondral trabecular bone. A total of 6 joints per group (6 MIA-treated sedentary rats, 5 saline-treated sedentary rats, 6 MIA-treated sedentary rats, and 4 MIA-treated exercise rats) were analyzed for the subchondral bones. For the metaphysis, some samples were not analyzed due to an insufficient area of analysis.
Statistical analysis. All statistical analyses were performed using GraphPad Prism. Sample sizes for all experiments were based on those typically reported in the literature. MIAinduced changes in weight bearing and tactile hypersensitivity were examined using two-way repeated measures analysis of variance (ANOVA) (exercise treatment 3 time), followed by analysis of exercise effects at each time point compared to day 7 (preexercise) using Bonferroni's post hoc test. Shock data were analyzed by using two-way repeated-measures ANOVA, followed by post hoc analysis using Tukey's multiple comparison test.
For the CPP and CPA experiments, the effects of exercise and conditioning chamber were analyzed using the Holm-Sidak test (at an alpha level of 5%). Computations were made under the assumption that all rows were samples from populations with the same scatter (standard deviation). Differences between groups were assessed using difference scores that were calculated as postconditioning (test) or pre-conditioning (baseline) time spent in the treatment-paired chamber. Statistical analyses for group comparisons were performed by one-way ANOVA, followed by analysis using the Holm-Sidak post hoc test. Micro-CT data were analyzed by two-way ANOVA, followed by post hoc analysis using Fisher's least significant difference test.
RESULTS
Tactile hypersensitivity and weight asymmetry. In sedentary rats, MIA-induced tactile hypersensitivity and weight asymmetry were present 7 days post-MIA treatment, and persisted for 7 weeks ( Figures 1B and C, respectively) . Exercise reversed the MIA-induced tactile hypersensitivity, with withdrawal thresholds returning to pre-MIA treatment values 35 days postinjection, corresponding to 4 weeks of exercise ( Figure 1B) . Exercise also reversed MIA-induced weight asymmetry, with significant improvement observed by day 21 post-MIA injection, and continued improvement seen between days 35 and 49. MIA-treated rats showed greatly diminished exposure to the shock pad after the first day on the treadmill ( Figure 1D ). Analysis of shocks per weekday across 4 weeks showed an elevated number on the first day of week 1, but only in exercised rats ( Figure 1E ).
Exercise blocks MIA-induced ongoing pain. IA lidocaine produced CPP selectively in the sedentary MIAtreated rats, but not in exercised MIA-treated rats ( Figure  2B ). IA lidocaine did not alter time spent in the lidocaine paired chamber in sedentary rats or in exercised rats that had been administered IA saline. RVM lidocaine also produced CPP in the sedentary MIA-treated rats but not in exercised MIA-treated rats ( Figure 2C ). RVM lidocaine failed to alter the amount of time spent in the lidocaine paired chambers in the IA saline-treated rats. Any rats with missed injections, defined by ink marks outside of the RVM ( Figure 2C ), were excluded from data analysis.
Naloxone induces CPA and unmasks weight asymmetry. In sedentary rats, MIA-induced weight asymmetry was present 35 days post-MIA treatment. MIAtreated rats that had undergone exercise for 4 weeks demonstrated normal weight bearing, with weight-bearing ratios equivalent to pre-MIA baseline values (P . 0.05). Treatment with systemic naloxone (3 mg/kg, administered IP) revealed weight asymmetry in MIA-treated exercised rats, with values returning to those observed in sedentary control rats ( Figure 3A) . To examine whether blocking of endogenous opioid signaling also unmasked ongoing pain, we investigated whether exercised rats that had received IA-MIA injections showed CPA to a chamber paired with naloxone (3 mg/kg, IP). Naloxone produced CPA in rats that had undergone 4 weeks of exercise, but not in sedentary rats ( Figure 3B ). Of interest, the naloxoneinduced CPA was observed in exercised rats irrespective of whether they had received IA saline or MIA ( Figure 3A) .
Effects of exercise on MIA-induced joint pathology. Weekly radiography of the femorotibial (knee) joint demonstrated a time-dependent progression of MIAinduced joint pathology in both the sedentary and exercise treatment groups (Figure 4 ). There were no apparent differences between exercised and sedentary rats.
Exercise-induced blockade of MIA-induced joint pathology demonstrated by micro-CT analysis. Threedimensional images from micro-CT scans revealed extensive bone remodeling within the femorotibial joint, with clear development of osteophytes as well as apparent pitting and lesions of the cortical bone ( Figure 5A ). Reconstructed images showing trabecular bone within the subchondral bone and metaphysis revealed diminished trabecular bone, particularly in the metaphysis of sedentary MIA-treated rats ( Figure 5A ). Exercise appeared to ameliorate the MIA-induced trabecular bone loss within the metaphysis ( Figure 5A ). Quantitative analysis of bone volume demonstrated that MIA-induced pathologic changes in sedentary rats occurred both in the metaphysis just below the epiphyseal plate and in both the lateral and medial subchondral bones (Figures 5B-D) . Within the metaphysis, MIA treatment diminished total trabecular bone volume in sedentary rats, but this was attenuated in exercised MIA-treated rats (Figure 5B) . MIA-treated rats demonstrated a significant decrease in bone volume of the lateral subchondral bone (measured 35 days post-MIA treatment) that was not altered by exercise ( Figure 5C ). Sedentary MIA-treated rats also had decreased trabecular bone volume in the medial subchondral bone ( Figure 5D ). This MIA-induced bone loss was blocked by exercise ( Figure 5D ). MIA treatment diminished trabecular thickness within the metaphysis of sedentary and exercised rats ( Figure 5E ). In the medial subchondral bone, MIA induced increased trabecular thickness in exercised rats compared to saline-treated rats ( Figure 5F ). Similarly, a significant increase in trabecular thickness was observed in the lateral subchondral bone of exercised MIA-treated rats compared to sedentary saline-treated control rats ( Figure 5G) .
Within the metaphysis, MIA treatment reduced the number of trabecular bone and increased trabecular spacing ) in the medial subchondral bone of MIA-treated sedentary, but not MIA-treated exercised, rats. C, Significant reduction in bone volume in the lateral subchondral bone of MIA-treated sedentary and exercised rats. D, Diminished bone volume in the trabecular region of the metaphysis in MIA-treated sedentary rats, which is attenuated in MIA-treated rats that underwent treadmill exercise. E, Significant reduction of trabecular bone thickness in the metaphysis of MIA-treated rats. F, Increased trabecular thickness in the lateral subchondral bone of MIA-treated rats. G, Increased trabecular thickness within the medial subchondral bone in MIAtreated rats that underwent exercise. * 5 P , 0.05; ** 5 P , 0.01; *** 5 P , 0.001 for the indicated comparisons or versus saline-treated sedentary rats.
in sedentary rats that was blocked by 4 weeks of exercise ( Figures 6A and B) . MIA treatment reduced connectivity density of trabecular bone in sedentary rats, but this was also blocked by 4 weeks of exercise ( Figure 6C) . Within the lateral and medial subchondral bone, no changes in trabecular number ( Figures 6D and G) , trabecular spacing ( Figures  6E and H) , or connectivity density ( Figures 6F and I) were observed in sedentary or exercised MIA-treated rats.
DISCUSSION
In our study we demonstrated that 4 weeks of treadmill exercise alleviates ongoing pain, restores weight bearing on the osteoarthritic knee, and alleviates hind paw tactile hypersensitivity in a rat model of advanced OA pain. The exercise-induced pain relief was dependent on endogenous opioids, illustrated by the ability of systemic administration of the opioid receptor antagonist naloxone to unmask weight asymmetry and produce CPA in exercised rats that had OA. Naloxone also produced CPA in control rats that had received IA saline, indicating that exercise increases endogenous opioid signaling in the absence of joint pathology and that blocking this signal is aversive.
Exercise also attenuated MIA-induced bone remodeling within the subchondral bone and metaphysis, indicating a potentially stabilizing effect of exercise. Notably, our observations that naloxone unmasked pain behaviors in the exercised rats indicates that these protective effects of exercise on the bone were likely independent of the pain-alleviating effects of exercise.
Our observation that 4 weeks of treadmill exercise reversed OA-induced tactile hypersensitivity and weight asymmetry is consistent with clinical studies demonstrating that exercise can improve joint function and diminish pain in patients with OA (16) . The reversal of weight asymmetry indicates an increased willingness of MIA-treated rats that had undergone exercise to load the joint, potentially reflecting improved use and function. Analysis of joint use and weight bearing while running warrants further study.
We further demonstrated that exercise reversed MIA-induced ongoing pain. IA lidocaine produced CPP in sedentary MIA-treated rats, consistent with previous observations that this concentration of MIA produces ongoing pain that is dependent on peripheral input from the joint (25) . In contrast, lidocaine treatment failed to induce CPP in exercised rats, indicating that the exercise blocked ongoing pain following MIA pain. This conclusion is further supported by the observation that RVM lidocaine produced CPP in sedentary but not exercised MIA-treated rats. RVM lidocaine-induced CPP in sedentary rats is consistent with our previous observations that blockade of descending (presumably facilitatory) output from the RVM induces CPP and supports the conclusion that advanced OA pain is dependent on descending painfacilitatory pathways (9, 26) .
Together, the data from previous observations and the present study indicate that MIA-induced knee joint pain is reversed by 4 weeks of treadmill exercise. An important aspect of these observations is that administration of lidocaine to the knee joint or RVM failed to alter the time spent in the lidocaine-paired chamber in control rats irrespective of treatment group. This suggests that lidocaine-induced CPP is specific to relief of OA-induced ongoing pain.
The findings in this model of OA suggest that exercise-induced pain relief may be observed in patients who develop persistent, NSAID-resistant joint pain. It has been suggested that development of moderate-to-severe pain in advanced OA is due to central sensitization and to neuropathic pain likely arising from damage to nerves (9, (31) (32) (33) . Several studies have demonstrated signs of central sensitization in preclinical studies of MIA-induced joint pain (9, 26, (34) (35) (36) . Electrophysiologic studies have demonstrated enhanced evoked responses of dorsal horn neurons in response to pinch and noxious mechanical stimuli within the spinal cord (34) . Other studies demonstrate that rats with MIA-induced knee joint OA show glial activation in the spinal cord (35) , a marker of spinal sensitization associated with release of proinflammatory cytokines and brain-derived neurotrophic factor (BDNF) (37) .
Whether exercise-induced pain relief may be due in part to suppression of proinflammatory factors released by spinal glia remains to be determined. In support of this possibility, several studies have demonstrated that exercise reduced proinflammatory factors including BDNF, glial activation, macrophage infiltration, and proinflammatory cytokines within the spinal cord in rat models of neuropathic pain (38) (39) (40) . Furthermore, exercise might be beneficial in that it diminishes proinflammatory cytokines within the dorsal root ganglion and the brain (39) . Further studies are needed to determine whether exercise decreases central microglial activation and associated proinflammatory factors that promote chronic pain.
Clinical observations indicate elevated levels of the endogenous opioid b-endorphin while running (41) . Animal studies have shown elevated levels of endogenous opioids in the serum (42) and brain regions (43) of rats, including elevated b-endorphin and met-enkephalin within the RVM and proliferation-associated gene protein (17) , key components of the descending pain modulatory pathways (44) . Endogenous opioids may block pain through multiple mechanisms including actions on mopioid receptors in the cortex as well as in subcortical regions, the spinal cord, and the periphery (44) . Moreover, spinal naloxone was demonstrated to block analgesia in Nav1.7 mutant mice, suggesting that tonic opioid signaling can maintain analgesia at the level of the spinal cord (45) . The release of endogenous opioids in the anterior cingulate cortex has been suggested as a general mechanism of pain relief (46) , consistent with the present observations. Endogenous opioids may also improve both pain and bone remodeling through indirect actions by blocking proinflammatory responses by glia or peripheral immune cells (39, 47) . Our observations that naloxone blocked the exercise-induced weight asymmetry is consistent with other studies demonstrating that naloxone blocked exerciseinduced reversal of thermal and tactile hypersensitivity in models of nerve injury and muscle pain (17, 20) . Previous studies have indicated that this is likely through descending pain-inhibitory pathways from the RVM, as administration of a peripherally restricted antagonist failed to block the exercise-induced blockade of evoked hypersensitivity, and RVM-administered naloxone reestablished the nerve-injury induced thermal and tactile hypersensitivity (17) . These observations suggest that exercise normalizes the balance of descending pain modulation, overcoming OA-induced net descending pain-facilitatory drive. RVM lidocaine in the MIA-treated exercised rats failed to induce CPA, likely because lidocaine inactivates both descending pain-inhibitory and pain-facilitatory pathways within the RVM (44) .
In addition to reestablishing weight asymmetry, naloxone produced CPA in MIA-treated exercised rats. This is consistent with the hypothesis that blockade of the opioid signaling unmasks ongoing pain, thereby creating an aversion to the naloxone paired chamber. However, naloxone also produced CPA in the exercised control rats that did not have knee OA. These observations indicate that treadmill exercise produces a tonic endogenous opioid signaling that, when blocked, creates a contrasting aversive state. This is consistent with observations that exercise stimulates the release of endogenous opioid peptides and increases nociceptive thresholds in human and animal studies (48) . In addition, chronic long-term exercise has been demonstrated to decrease sensitivity to morphine and other mopioid receptor agonists, suggesting that exercise may lead to cross-tolerance to exogenously administered opioid agonists and dependence (48) . Supporting this idea, naloxone has been reported to precipitate a mild withdrawal syndrome in exercised, but not sedentary, rats (48) . The CPA observed in MIA-treated rats may result from unmasking knee joint pain, a conclusion supported by the observation that naloxone also produces weight asymmetry. However, we acknowledge that other, non-pain-associated factors may contribute to naloxone-induced CPA.
Preclinical studies have demonstrated that MIA causes time-and concentration-dependent cartilage loss (25, 49) and progressive changes to subchondral bone in a time-dependent manner (50) (51) (52) . Micro-CT analysis of tibias indicates that treadmill exercise blocked MIA-induced trabecular bone loss. Thus, exercise has protective effects on trabecular bone degradation in this model of advanced OA pain. Our data are consistent with reports that interval training on a treadmill prevents MIA-induced decreased bone mineral density in the proximal tibia (52) . Moreover, these data are consistent with other observations that lightto-moderate, but not intense, exercise has a protective effect on joint pathology in a surgical model of OA (53) . The potential protective effects of exercise on bone remodeling and joint pathology support the conclusion of a recent meta-analysis indicating that running has protective effects against knee joint surgery in OA (54) .
Our data demonstrate that naloxone reestablished pain behaviors characteristic of OA pain, indicating that the protective effects of exercise on bone remodeling within the tibia are likely to be independent of the pain-alleviating effects of exercise. The mechanism by which exercise ameliorates degeneration of trabecular bone deserves further study. Potential contributing factors may include the antiinflammatory effects of endogenous opioids, as indicated by the antiinflammatory effects of met-enkephalin demonstrated in a model of inflammation-associated arthritis (47) . With regard to exercise, both clinical and preclinical studies have demonstrated that regular exercise diminishes proinflammatory markers in peripheral tissue (39) .
Whether endogenous opioids mediate potential exercise-associated antiinflammatory effects that diminish advanced OA-induced bone remodeling and joint pain deserves further exploration. It should be noted that other factors, such as potential increased weight bearing on the joint during exercise, may also contribute to the protective effects observed in the exercised rats. Additionally, future studies examining other aspects of joint function and use, such as joint stiffness and range of motion, are warranted to further explore potential protective effects of exercise on the joint.
In conclusion, our studies indicate that exercise may improve pain in patients with advanced OA, resulting in an overall improvement in the quality of life of these patients. In addition, the protective effects of exercise on OA-associated bone remodeling may be able to prevent or delay joint replacement therapy in patients with OA. Taken together, these studies indicate potential protective effects of exercise in advanced OA joint pathology.
